Spectral AI, Inc.

Spectral AI, Inc. (Nasdaq: MDAI) is a medical technology company that completed its de-SPAC business combination and filed a 10-Q quarterly report on May 12, 2023, reflecting its standing as a post-merger public registrant. Operating in the healthcare and artificial intelligence sector, Spectral AI develops clinical diagnostic platforms focused on wound assessment, with its lead technology using deep learning and multispectral imaging to predict burn wound healing outcomes in real time. The company lists its common stock on Nasdaq under the ticker MDAI and continues to advance its platform through clinical and regulatory development. For full SPAC deal history, sponsor details, and ongoing filing coverage for MDAI and the broader SPAC universe, sign up for SpacDesk.